Bringing Cure...Building Hope...
Home | Blog | Events

Investigational Drugs For COVID 19

IPN, New Delhi can facilitate patient to import of "COVID 19" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

List of Investigational Drugs for COVID 19 Treatment

On 31 December 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on 7 January 2020 and was temporarily named “2019-nCoV”. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases. A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. The new virus was subsequently named the “COVID-19 virus”

The following lists COVID 19 drugs, Under the authorization, molnupiravir may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which molnupiravir belongs (i.e., anti-infectives). Molnupiravir is not FDA-approved to prevent or treat any diseases or conditions, including COVID19. Molnupiravir is an investigational drug. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

MOVFOR

Movfor (Molnupiravir) 200 mg Capsules.

More Details...
MOLFLU

Molflu (Molnupiravir) Capsules 200 mg

More Details...
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

CONTACT DETAILS
IPN, New Delhi India
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838
Email: info@indianpharmanetwork.co.in
Social Media:

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved COVID 19 medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of COVID 19 Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of COVID 19, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur

US FDA Approved Oncology Drugs

For Leukemia

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

US FDA Approved Oncology Drugs

For Multiple Myeloma

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian FDA Approved Oncology Drugs

For Melanoma

The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in